Table 5 Evaluation performance (%) of the proposed ReMLA at \(rf=5\) and \(rf=7\)/full FEN).
Isoforms | Acc | AUC | AUC-PR | Sen | Spe | MCC | F1-score | Pre |
---|---|---|---|---|---|---|---|---|
CYP1A2 | 79 | 94 | 82 | 87 | 91 | 69 | 77 | 67 |
CYP2C9 | 82 | 97 | 88 | 88 | 94 | 72 | 79 | 70 |
CYP2C19 | 81 | 95 | 84 | 89 | 92 | 70 | 78 | 68 |
CYP2D6 | 84 | 98 | 90 | 86 | 95 | 68 | 80 | 66 |
CYP3A4 | 77 | 97 | 88 | 89 | 93 | 73 | 78 | 75 |
Average | 80.8 | 96.2 | 86.4 | 87.8 | 93.2 | 70.5 | 78.4 | 69.2 |